Literature DB >> 518865

Complete amino acid sequence of a papain-solubilized human histocompatibility antigen, HLA-B7. 2. Sequence determination and search for homologies.

H T Orr, J A López de Castro, D Lancet, J L Strominger.   

Abstract

The complete amino acid sequence of the papain-solubilized heavy chain of a human histocompatibility antigen (HLA-B7) has been elucidated. It consists of a polypeptide of 271 residues (31 333 daltons). A single glycan moiety is attached to an asparagine residue at position 86 by an N-glycosidic bond. Two intrachain disulfide bonds, arranged linearly, involve half-cystine residues at positions 101 and 164 and at positions 203 and 259. They form two loops of 62 and 55 residues, respectively, separated by 38 residues. Computer analysis of the sequence suggests the existence of internal homology between the amino-terminal portion (residues 1--90) and the region of the first disulfide loop (residues 91--180). There is a significant homology between the second disulfide loop region of the chain (residues 182-271) and immunoglobulin (Ig) constant domains and beta 2-microglobulin [Orr, H. T., Lancet, D., Robb, R. J., López de Castro, J. A., & Strominger, J. L. (1979A) Nature (London) (in press)]. However, no such homology to Ig is apparent in the amino-terminal or in the first disulfide loop regions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518865     DOI: 10.1021/bi00592a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  A transposable epitope of HLA-B7, B40 molecules.

Authors:  J P Ways; D A Lawlor; A M Wan; P Parham
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.

Authors:  C Layet; T Delovitch; P Ferrier; D H Caillol; B R Jordan; F A Lemonnier
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 3.  Organization of the human class I major histocompatibility complex genes.

Authors:  B H Koller; D Geraghty; H T Orr; Y Shimizu; R DeMars
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Structure and polymorphism of class I MHC antigen mRNA.

Authors:  A K Sood; J Pan; P A Biro; D Pereira; R Srivastava; V B Reddy; B W Duceman; S M Weissman
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  PharmGKB summary: carbamazepine pathway.

Authors:  Caroline F Thorn; Susan G Leckband; John Kelsoe; J Steven Leeder; Daniel J Müller; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-12       Impact factor: 2.089

6.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Transfection of murine LMTK- cells with purified HLA class I genes. VII. Association of allele- and locus-specific serological reactivities with respectively the first and second domains of the HLA-B7 molecule.

Authors:  R Sodoyer; B Kahn-Perles; T Strachan; J Sire; M J Santoni; C Layet; P Ferrier; B R Jordan; F A Lemonnier
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  A new public antigen shared by all HLA-A locus products except HLA-A23, -A24, -A32, and -A25 is probably influenced by the amino acid residue at position 79 in the alpha 1 domain.

Authors:  L P de Waal; C van der Meer; A R van der Horst; F H van der Velde
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells.

Authors:  D S Singer; R D Camerini-Otero; M L Satz; B Osborne; D Sachs; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Anti-HLA antibodies of predetermined specificity: a chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain.

Authors:  W R Church; L E Walker; R A Houghten; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.